NCT01856413 A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant Status COMPLETED Phase PHASE3
NCT01847430 Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder Status COMPLETED Phase PHASE4
NCT01821547 New Methods to Measure the Immune Response to Hepatitis B Vaccine Status COMPLETED Phase PHASE4
NCT01810835 Prevention of Hepatitis B Virus Mother-to-child Transmission by Serovaccination. Status COMPLETED Phase N/A
NCT01796457 HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01790633 Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests Status COMPLETED Phase NA
NCT01782794 Acceptability of Hepatitis B Vaccination in General Population Status COMPLETED Phase N/A
NCT01777295 Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System Status COMPLETED Phase PHASE2
NCT01777074 Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians Status COMPLETED Phase N/A
NCT01772121 Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India Status COMPLETED Phase N/A
NCT01768195 Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy Status UNKNOWN Phase PHASE4
NCT01767597 Application of HBV Rapid Tests as a Tool for Wide-Use Screening Status COMPLETED Phase NA
NCT01765231 Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma Status UNKNOWN Phase PHASE4
NCT01732081 "Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection Status UNKNOWN Phase N/A
NCT01727271 A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384) Status WITHDRAWN Phase PHASE4
NCT01720238 Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis Status UNKNOWN Phase N/A
NCT01715987 Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment Status TERMINATED Phase N/A